Louisiana Senate Bill 213 was introduced, proposing a workers’ comp medical fee schedule. The bill requires the Office of Workers' Compensation Administration to update the schedule biennially, utilizing RVUs from...
The Colorado Division of Workers’ Compensation (DWC) will host three virtual listening sessions to gather input on implementing House Bill 1300, which introduces major reforms to the state’s workers’ compensation system...
...improve oversight of financial activities, and demonstrate respect for state authority over marijuana regulation. The committee is also seeking feedback on other draft bills that focus on technical revisions to...
...entire ancillary service process Enhances performance management through insightful analytics and key metrics Motivation for a New ABM Model Ancillary benefits account for over 40% of workers’ comp medical spend, but managing...
...to 365,000 cases in 2022. This 2022 increase in respiratory illness comes after a drop in 2021. The combined illness-and-injury frequency rate was 2.7 cases per 100 full-time equivalent (FTE)...
...tablets. Meanwhile Lannett Company, Inc. is recalling ranitidine syrup for similar impurities of NDMA, as is American Health Packaging. Furthermore, the FDA is now advising other companies to recall their ranitidine if testing shows levels...
...are at a significantly higher likelihood to develop chronic conditions that can lead to more complex workers’ comp claims, as claims with comorbidities require additional care, medications, and costs. To...
...would let workers designate any Level I or Level II accredited physician as their treating doctor. In Kansas, both House Bill 2312 and Senate Bill 203 would allow patients their choice of physician, requiring...
...Bill 309 was introduced recently, which would require workers’ comp and automobile insurance carriers to provide coverage for costs associated with the use of medical cannabis. This comes after the...
...the workers’ comp industry. Nearly 60% of respondents identified workers’ comp litigation as a top concern, followed closely by poor worker health, comorbidities, and social determinants of health. The article...
...the treatment of acute pain. The test is not intended to be used in patients being treated for chronic pain. The AvertD test is a prescription-use only genetic laboratory test...
With dozens of manufacturers providing various types of diagnostic tests for COVID-19, several companies have created serological (antibody) tests. Many manufacturers have received Emergency Use Authorizations (EUA) for tests they...
The FDA issued an emergency use authorization (EUA) for LabCorp’s COVID-19 RT-PCR test to permit testing of samples self-collected by patients at home using a special home collection kit. Headlines...
